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1959-1041The 4 control dogs showed no significant differences in AFR generation
when comparing shocks administered before and after saline infusion rather
than SOD/CAT. Conclusion: antioxidant enzymes markedly attenuate free
radical generation by DC shocks. If free radicals are a mechanism of de-
fibrillation injury in patients, drugs with free radical inhibiting or scavenging
properties may prevent such injury,
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There were no in-hospital deaths in any of these patients. This protocol ap-
pears safe, can be systematically applied to include all patients who present
with CP, and will thus help maximize resource utilization by appropriately
triaging patients and reducing LOS.
Level Predicted Risk of AMI % Patients AMI(%) CCU LOS
1 >95% 4% 100% 2.9 days
2 50-95% 31% 21% 1.7 days
3 5-50% 23% 3% 21 hrs
4 <5% 42% 0% 0
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Emergent myocardial perfusion imaging IMPI) has been shown to be accu-
rate in diagnosis of acute MI. We assessed the financial and pt outcome
implications of such imaging.
Method: 50 pts presenting to emergency center (Ee) with unexplained
chest pain received resting Tc99m-sestamibi SPECT MPI as part of their
EC evaluation with a gamma camera dedicated to this purpose. If resting
scan was nl, adenosine stress imaging was performed in EC at cardiologist's
(MOl discretion. Influence of MPI was determined by MD questionnaire com-
pleted immediately before and after MPI results were made available. Cost
savings analysis was based on pre- vs post-MPI management strategy and
historical analysis of costs. 45 pts were followed avg 9 months post MPI.
Results: MPI altered pt management in 34/50 pts (68%).29 pts were sent
home rather than admitted based on EC MPI. 9/21 admitted pts were sent
to lower intensity beds. Total cost savings was $88,533 ($1771/pt). 35 pts
were asymptomatic on follow-up, 8 had recurrent chest pain and 6 had at
least 1 EC visit for chest pain. No pt with nl MPI had a major cardiac event
or revascularization on follow-up.
Conclusion: The use of acute EC SPECT MPI is a cost effective means of
assigning pts to a low risk group that may be followed safely on an outpatient
basis.
Recent studies suggest the mechanism of sudden death in congestive heart
failure (CHF) patients is less frequentlyVTNF than previously believed. In or-
der to further understand the characteristics and mechanisms of death in
CHF patients, we evaluated 146 patients who underwent cardiopulmonary
resuscitation during hospitalization for congestive heart failure, ischemic
heart disease, and noncardiac causes. Clinical characteristics and outcomes
are described below:
Automated external defibrillators use ECG analysis algorithms to identifyven-
tricular fibrillation IVF) and ventricular tachycardia (VT). VT can be associated
with a wide range of blood pressures and automated defibrillators determine
the need for DC shock based on the heart rate alone. The incorporation of a
hemodynamic sensor may improve the accuracy of an automated defibrilla-
tor. The impedance cardiogram (ICG) has been used to non-invasively mea-
sure cardiac output and its peak value, dz/dt(max), correlates well with aortic
blood flow. We have developed a system whereby the ICG can be recorded
at cardiac arrests through the same two ECG/defibrillator pads, placed in an
antero-apical position, that are used to monitor or shock the patient. At 103
cardiac arrest calls and in 20 healthy volunteers (C) the ICG was recorded
for a period of at least lOs without CPR artefact: 9 records were rejected be-
cause of poor quality. The rhythms were divided into VF, asystole (As). agonal
rhythm lAg), electromechanical dissociation (EMD). VT requiring DC shock
(VTs) and VT not requiring DC shock (VTns). The ICG tracings were ensemble
averaged to remove any electrical noise and dz/dt(max) was measured.
C was significantly greater than all other rhythms. VTns was significantly
greater than the pulseless rhythms EMD, Ag, VF and As. There was no sig-
nificant difference between VTs and the pulseless rhythms. Thus the ICG is
a potential hemodynamic sensor for automated external defibrillators.
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What "Dose" of Oxygen is Required in Treating
Prolonged Cardiac Arrest
A Systematic Approach to the Evaluation of
Chest Pain in the Emergency Department: A
Prospective Risk Assessment and Treatment
Protocol Based on Patient Presentation, ECG
and Rest Technetium 99m-Sestamibl
Introduction: Selective aortic (Ao) perfusion and oxygenation (SAPO) with
oxygenated ultra-purified polymerized bovine hemoglobin (UPBH) is an effec-
tive adjunct to ACLS in the treatment of cardiac arrest. The optimal volume
of oxygenated UPBH, equivalent to a dosage of oxygen, is not known.
Purpose: Determine the doselresponse relationship between intra-Ao
UPBH and return of spontaneous circulation (ROSC).
Methods: Randomized, interventional study using a canine model of VF
with a prolonged "down-time" and CPR based on external chest compres-
sion. After chloralose anesthesia, the blood gases and vital signs were nor-
malized. ECG, Ao arch and intra-esophageal pressures were measured con-
tinuously, A descending Ao occlusion-infusion balloon catheter was placed
through the femoral artery. Ventricular fibrillation was induced and BLS be-
gun after 10 min, Inter-animal differences in BLS were minimized by stan-
dardization of esophageal pulse pressure and Ao blood gases. At 13 min.
the Ao occlusion balloon was inflated and 10,20 or 30 cclkg of UPBH (equiv-
alent to 1.8,3.6, and 5.4 ml 021kg) was infused at 300 cc/min. Defibrillation
with 8 Jlkg was attempted at end infusion. Results: N = 17. Only 2 of 5 an-
imals given 10 cc/kg of UPBH had ROSC, verses 4 of 5 given 20 cclkg, and
all 7 animals given 30 cclkg had ROSC (p = 0.05). All resuscitated animals
were alive at one hour. Conclusions: There is a dose-response relationship
between the volume of oxygen administered by SAPO and the rate of ROSC
after prolonged cardiac arrest. Thirty cc/kg of UPBH, equivalent to 5.4 ml
021kg, appeared optimal in this model.
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Ideal treatment of acute myocardial infarction (AMI) and unstable angina (UA)
require rapid evaluation and triage in the ED. Appropriate patient triage and
disposition can reduce admissions and optimize resource utilization includ-
ing reduced CCU length of stay (LOS). Historically less than 20 percent of
patients admitted with chest pain (CP) rule in for AMI. However, all patients
must be initially evaluated in the same fashion until the risk of AMI or UA
can be determined and appropriate treatment initiated. Given the diagnostic
limitation of the presenting symptoms and initial ECG, we designed and are
prospectively testing a systemic protocol to evaluate all patients who present
to the ED with CP All patients are assigned to one of five levels based on risk
and probability of AMI and of ischemia: 1. AMI; 2. Probable AMI/UA; 3. Pos-
sible AMI/UA; 4. Possible UA; and 5. Non-cardiac CPO In the absence of a
diagnostic ECG needed for assignment to levell, (ST elevation), or level 2,
(ST depression). immediate injection of Tc99m-sestamibi in the ED is used to
further stratify patients in levels 3 and 4. If the evaluation of any given patient
becomes positive, the assigned level is increased to one of higher risk with
appropriate changes in therapy.
Since January 1994, 560 patients with potential cardiac chest pain have
been enrolled into levels 1-4. Level 5 patients were treated for obvious non-
cardiac causes. Predicted risk of AMI with distribution of patients and actual
incidence of AMI is as follows:
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CHF/Cardiac nonCHF/Cardiac noncardiac
N 30 26 90
Age 63 (4971) 67 (6072) 63(2971)
Sex (% male) 37 58 60
Initial Rhythm N(%)
vrNF 7 (25) 11 (44) 24 (27)
Asystole 6 (21.4) 6(24) 33 (37.5)
Bradycardia 5 (17.9) 2 (8) 6(6.8)
EMD 6 (21.4) 1(4) 13(148)
Other 4 (14.3) 5 (20) 12(136)
ROSC 21 (70) 13 (50) 51 (567)
Survival to D/C 1(3.3) 4 (15.4) 2 (2.2)
Results: group A group B
ATP-tested yes no
patients (n) 18 48
VT episodes 532 491
ATP-termination 468 430
ATP unsuccessfull 29 41
VT-acceleration 35(6.6%) 20 (4.7%)
AlP-success rate 88% 88%
Conclusion: The autodecremental ramp is a safe and effective antitachy-
cardia pacing mode for terminating spontaneous ventricular tachycardias in
88% regardless of the result of the pre-discharge test.
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Patients with nonCHF/Cardiac disease had a higher ROSC than patients
with CHF and noncardiac diseases (p = 0.016). In summary, patients with
CHF often experience cardiopulmonary arrest with bradycardic or EMD ar-
rests. Although patients with CHF are resuscitated with a high degree of suc-
cess their in-hospital survival was low. Furthermore, the high rate of brady-
cardic and EMD arrests may explain the low in-hospital survival rates.
Implantation of a Single-Lead Unipolar
Transvenous Cardioverter/Defibrillatior (ICD)
Under Local Anesthesia
Therapy A B C D global p
PCl/No B 91/7 81/7 91/15 81/15
Allvr 68% 46% 85% 61% 69% <0.001
VTCL < 350· 82% 14% 44% 38% 47% 0.03
VTCl> 350 73% 100% 91% 86% 90% ns
Burst antitachycardia pacing (ATP) is higly efficacious for termination
of monomorphic ventricular tachycardia (MVT). Since several pacing se-
quences are usually programmed as a single therapy. optimal programming
is presently unknown. In 40 patients (P) with MVT and a 3rd generation AICD,
4 burst ATP were prospectively compared (as a first single ATP) during follow-
up in a randomized design crossing over every 2-3 months. Burst ATP modes
(A to D) were defined by pacing cycle length (PCl, as % of VTCl) and num-
ber of beats (No B) (Table). A second ATP zone was programmed in a non
selected way in all patients.
Results (Table): 374 episodes (317 considered MVT) received ATP thera-
pies in 23 patients. RR intervals could be retrieved for MVT-Cl analysis in
168 episodes. Succes rate of combined first (randomized) and second (non
selected) therapies was 92%. Acceleration rate estimation was 2%.
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The purpose of this study was to prospectively evaluate single-lead unipolar
transvenous ICD implantation under local anesthesia and defibrillator thresh-
old testing under mild sedation.
In 12 consecutive patients (mean age. 61 ± 10 years) transvenous ICD im-
plantation was performed (9 patients had ischemic heart disease. 3 patients
dilated cardiomyopathy). The presenting arrhythmia was ventricular fibrilla-
tion in 4 patients. and monomorphic ventricular tachycardia in 8 patients.
Mean lVEF was 26 ± 11 %. A single-lead unipolar transvenous ICD with
biphasic defibrillation pulse was implanted subpectorally in all patients un-
der local anesthesia with 1% lidocaine. During defibrillation threshold (OFT)
testing sedation was applied with 11.5 ± 5.1 mg (0.14 ± 0.05 mglkg) mi-
dazolam. For DFT determination 5.8 ± 1.3 episodes of ventricular fibrillation
(mean total ventricular fibrillation time 52.4 ± 14.7 seconds) were induced.
Mean OFT was 12.8 ± 4.3 J. mean duration of the implantation procedure
was 58 ± 13 minutes. Heart rate. mean arterial blood pressure. and arterial
oxygen saturation were not significantly different before and after DFT deter-
mination. One patient had moderate pain during DFT testing. and 3 patients
had mild pain during the surgical procedure. Symptoms during the proce-
dure were evaluated using a standardized questionnaire. Severe feeling of
panic and surprise, and discomfort of moderate degree was reported by 2
patients. There were no complications. Hospital length of stay: all patients
were discharged on the second postoperative day. Postimplant ICD testing
was performed successfully without sedation 35 ± 1.4 days after ICD im-
plantation, in 6 patients as an outpatient procedure.
Conclusions: Single-lead unipolar transvenous ICD systems can safely
be implanted under local anesthesia and mild sedation during defibrillation
threshold testing. The procedure is well tolerated.
• Cl < 350: group of Mvr with Cl < 350 ms. 0 Cl > 350: Mvr with Cl > 350 ms
Conclusions: 1. Efficacy of the tested burst pacing modes differs signifi-
cantly, at least in fast VT. 2. Contrary to what could be expected. "less agres-
sive" bursts seem to be more efficacious, even in fast VT.
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Cerebral and overall performance after successful resuscitation is an impor-
tant measure of its success. To evaluate resuscitation attempts in adults (age
:0: 18 years) by the 24-hrs resuscitation team in our hospital (1,032 beds;
27,500 admissions/years), we prospectively collected data from resuscita-
tion forms and retrospectively from medical records. Performance was as-
sessed retrospectively by means of the Cerebral and Overall Performance
Categories (CPC/OPC).
Results: A total of 1205 calls were received from June 1988 up to Jan-
uary 1994 (the emergency room and general wards always call upon the
team, CCU/ICU only when intubation is required). 717/1205 calls were con-
firmed arrests in 675 adults (mean age 58, 43% >70 years). Resuscitation
was not attempted in 10 arrests. Return of spontaneous circulation occurred
in 347/717 arrests (49%). followed by transfer to the ICU or CCU. Of the 347
initial survivors 93 (27%) died within 24 hrs. and another 138 (40%) died later
during their hospital stay. 101 (15%) pts (38% > 70 years) were discharged
from the hospital alive. VFNT as initial rhythm was present in 60 (60%) sur-
vivors and ischaemic heart disease (ICD 41 0-414)was diagnosed in 40 (40%)
survivors.
Outcome performance was assessed at the time of discharge. Good
outcome: CPC1, 90 pts (90%); OPC1, 78 (78%); Moderate disabilities:
CPC2. 4 pts (4%); OPC2, 14 pts (14%); Severely disabledlvegetative state:
CPC/OPC3-4, 7 pts (7%). A total of 36 pts (36%) died after discharge. of
which 19 (53%) died within the first year.
Conclusion: Survivors after of in-hospital circulatory arrest have a good
prognosis in terms of cerebral and overall performance, but long term suc-
cesses are limited.
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The value of testing antitachycardia pacing (ATP) for the termination of
ventricular tachycardias (VT) in implantable defibrillators was evaluated in
a prospective trial. Pre-discharge testing of antitachycardia pacing was
attempted in 66 consecutive patients (pts) with non-thoracotomy third-
generation implantable cardioverter-defibrillators (ICD). VT's could be in-
duced in 18 pts (group A: 14 CAD, 3 DCM. 1 other) and were terminated
by ATP at the pre-discharge testing at least twice. In 48 pts (group B: 30
CAD,9 DCM, 9 others) the effectivity of ATP could not be tested due to non-
inducible VT ATP was programmed in both groups as an autodecremental
ramp with 81 % of the tachycardia cycle length and up to 4 sequences with
8 to 11 stimuli. The mean follow-up was 10 months
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